SK bioscience Secures Major Funding to Propel RSV Antibody Development Globally SK bioscience has secured funding from the RIGHT Foundation to advance the development of an RSV preventive monoclonal antibody. This pivotal support will enhance clinical trials for transforming global health.

SK bioscience Secures Major Funding to Propel RSV Antibody Development Globally #South_Korea #Incheon #SK_bioscience #RSV_antibody #RIGHT_Foundation